| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Retro-2 |
2,3-DIHYDRO-2-(5-METHYL-2-THIENYL)-3-PHENYL-4(1H)-QUINAZOLINONE |
1429192-00-6 |
详细
|
| Lipofermata |
5-溴-5'-苯基-3'H-螺环[吲哚啉-3,2'-[1,3,4]噻二唑]-2-酮 |
297180-15-5 |
详细
|
| Glasdegib |
格拉斯吉布 |
1095173-27-5 |
详细
|
| PLX5622 |
PLX5622 |
1303420-67-8 |
详细
|
| Abexinostat (PCI-24781) |
PCI-24781 |
783355-60-2 |
详细
|
| Aurora kinase inhibitor III |
AURORA KINASE INHIBITOR III |
879127-16-9 |
详细
|
| NDI-091143 |
NDI-091143 |
2375840-87-0 |
详细
|
| ZT-12-037-01 |
ZT-12-037-01 |
2328073-61-4 |
详细
|
| LEE011 (Ribociclib) |
瑞博西尼 |
1211441-98-3 |
详细
|
| Derazantinib (ARQ 087) |
德拉赞替尼 |
1234356-69-4 |
详细
|
| AZD0364 |
CS-2696 |
2097416-76-5 |
详细
|
| Ponesimod |
PONESIMOD |
854107-55-4 |
详细
|
| ALK inhibitor 2 |
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺 |
761438-38-4 |
详细
|
| Emedastine |
依美斯汀 |
87233-61-2 |
详细
|
| SGI-1776 |
SGI-1776 |
1025065-69-3 |
详细
|
| SNS-062 |
SNS062 |
1270014-40-8 |
详细
|
| GDC-0623 |
GDC-0623 |
1168091-68-6 |
详细
|
| cGAMP |
C-GPAP |
849214-04-6 |
详细
|
| GSK2982772 |
GSK2982772 |
1622848-92-3 |
详细
|
| APY29 |
APY29 |
1216665-49-4 |
详细
|
| Autophinib |
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE |
1644443-47-9 |
详细
|
| SAR-20347 |
CPDD1211 |
1450881-55-6 |
详细
|
| R1487 |
SY-R1487 |
449808-64-4 |
详细
|
| SRT2104 (GSK2245840) |
玻玛西林 |
1093403-33-8 |
详细
|
| AST487 |
AST 487 |
630124-46-8 |
详细
|
| PD-166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐 |
212391-63-4 |
详细
|
| Volitinib |
沃利替尼 |
1313725-88-0 |
详细
|
| BBT594 |
BBT594 |
882405-89-2 |
详细
|
| Entospletinib (GS-9973) |
GS-9973 |
1229208-44-9 |
详细
|
| URMC-099 |
URMC-099 |
1229582-33-5 |
详细
|
| 4SC-202 tosylate |
4SC-202(盐的形式) |
1186222-89-8 |
详细
|
| LY2606368 dihydrochloride |
CHK1抑制剂 |
1234015-54-3 |
详细
|
| M-2951 (Evobrutinib) |
埃沃布鲁替尼 |
1415823-73-2 |
详细
|
| GSK-3326595 |
GSK-3326595 |
1616392-22-3 |
详细
|
| Rocilinostat (ACY-1215) |
ACY1215 |
1316214-52-4 |
详细
|
| SGC0946 |
SGC0946 |
1561178-17-3 |
详细
|
| ML792 |
ML792 |
1644342-14-2 |
详细
|
| AMG-510 |
AMG-510(消旋体) |
2252403-56-6 |
详细
|
| LY2886721 HCl |
N-[3-[(4AS,7AS)-2-氨基-5,7-二氢-4H-呋喃并[3,4-D][1,3]噻嗪-7A(4AH)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺盐酸盐 |
1262036-49-6 |
详细
|
| FEN1 Inhibitor C3 |
3-羟基-1-(4-甲氧基苯基)喹唑啉-2,4(1H,3H)-二酮 |
2109805-87-8 |
详细
|
| FEN1 Inhibitor C2 |
FEN1 Inhibitor C2 |
1995893-58-7 |
详细
|
| JNJ26854165 2HCl |
Quisinostat 二盐酸盐 |
875320-31-3 |
详细
|
| Fumagillol |
烟曲霉醇 |
108102-51-8 |
详细
|
| ACH-4471 |
Danicopan |
1903768-17-1 |
详细
|
| NTP-42 |
NTP-42 |
2055599-51-2 |
详细
|
| IDE196 |
LXS-196 |
1874276-76-2 |
详细
|
| BI671800 |
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸 |
1093108-50-9 |
详细
|
| KD025 (SLx-2119) |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 |
911417-87-3 |
详细
|
| TD-4208 |
雷芬那辛 |
864750-70-9 |
详细
|
| VLX600 |
VLX600 |
1622945-04-3 |
详细
|
| LY-3381916 |
LY-3381916 |
2166616-75-5 |
详细
|
| AZD 7648 |
AZD-7648 |
2230820-11-6 |
详细
|
| CPI-444 |
CPI-444 |
1202402-40-1 |
详细
|
| E-7046 |
E-7046 |
1369489-71-3 |
详细
|
| Pixantrone maleate |
马来到匹杉琼 |
144675-97-8 |
详细
|
| leniolisib(CDZ 173) |
LENIOLISIB |
1354690-24-6 |
详细
|
| BIIB057 HCl |
PRT062607 (HYDROCHLORIDE) |
1370261-97-4 |
详细
|
| FK866 |
(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide |
1198425-96-5 |
详细
|
| SNX-5422 |
SNX-5422 |
908115-27-5 |
详细
|
| N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide |
GSK2981278 |
1474110-21-8 |
详细
|
| MSDC 0160 |
MSDC-0160 |
146062-49-9 |
详细
|
| Ki2 0227 |
Ki20227 |
623142-96-1 |
详细
|
| Nelonicline |
Nelonicline |
1026134-63-3 |
详细
|
| 2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl] |
化合物BET BROMODOMAIN INHIBITOR |
1505453-59-7 |
详细
|
| BAY1125976 |
CS-2913 |
1402608-02-9 |
详细
|
| Capromorelin |
卡普瑞林 |
193273-66-4 |
详细
|
| FM381 |
(E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE |
2226521-65-7 |
详细
|
| CNX2006 |
CNX2006 |
1375465-09-0 |
详细
|
| IWP-O1 |
IWP-O1 |
2074607-48-8 |
详细
|
| MK-8353 (SCH900353) |
化合物 T12069 |
1184173-73-6 |
详细
|
| Larotrectinib (LOXO-101 sulfate) |
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐 |
1223405-08-0 |
详细
|
| V-9302 |
V-9302 |
1855871-76-9 |
详细
|
| DC661 |
DC661 |
1872387-43-3 |
详细
|
| LIT-927 |
LIT-927游离 |
2172879-52-4 |
详细
|
| BAY-8002 |
2-(2-氯-5-(苯基磺酰基)苯甲酰氨基)苯甲酸 |
724440-27-1 |
详细
|
| KO-947 |
KO-947 |
1695533-89-1 |
详细
|
| BLU-782 |
BLU-782 |
2141955-96-4 |
详细
|
| ARN-3236 |
3-(2,4-二甲氧基苯基)-4-(3-噻吩基)-1H-吡咯并[2,3-B]吡啶 |
1613710-01-2 |
详细
|
| Avapritinib (BLU-285) |
阿伐普替尼 |
1703793-34-3 |
详细
|
| Tomivosertib eFT508 |
6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮 |
1849590-01-7 |
详细
|
| CP 640186 |
(R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL |
591778-68-6 |
详细
|
| MB-07811 ( VK-2809) |
MB-07811 |
852948-13-1 |
详细
|
| Sparsentan (RE-021) |
4'-[(2-丁基-4-氧代-1,3-二氮杂螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-异恶唑基)-2'-(乙氧基甲基)-[1,1'-联苯]-2-磺酰胺 |
254740-64-2 |
详细
|
| Rogaratinib |
罗加替尼 |
1443530-05-9 |
详细
|
| ETC-1002 |
贝派地酸 |
738606-46-7 |
详细
|
| C75 |
反-4-羧基-5-辛基-3-甲基-丁内酯 |
191282-48-1 |
详细
|
| Fatostatin A |
FATOSTATIN A |
125256-00-0 |
详细
|
| TH 5487 |
TH 5487 |
2304947-71-3 |
详细
|
| BO-264 |
BO-264 |
2408648-20-2 |
详细
|
| NS-3-008 |
NS-3-008（HCl） |
1172854-54-4 |
详细
|
| MAC-545496 |
MAC-545496 |
838810-96-1 |
详细
|
| ML-109 |
ML-109 |
1186649-91-1 |
详细
|
| SGC2085 |
SGC2085 |
1821908-48-8 |
详细
|
| SD-06-1 |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 |
271576-80-8 |
详细
|
| ON123300 |
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
详细
|
| PD0166285 |
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
185039-89-8 |
详细
|
| PD173955 |
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 |
260415-63-2 |
详细
|
| GlyH-101 |
GLYH 101 |
328541-79-3 |
详细
|
| BMS-687453 |
BMS 687453 |
1000998-59-3 |
详细
|
| Dynasore |
DYNASORE |
304448-55-3 |
详细
|